Neoadjuvant Envafolimab Plus Disitamab Vedotin and Carboplatin in Resectable HER2-Mutant Non-Small-Cell Lung Cancer
Clinical trial NCT06734182 · RECRUITING
Trial details
- NCT number
- NCT06734182
- Sponsor
- Guangdong Provincial People's Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-22
- Primary completion
- 2027-06-22
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.